Nabriva Therapeutics PLC (NBRV) Stock Skyrockets Following Disclosure of Highly Promising Topline Data Results
Nabriva Therapeutics PLC (NBRV) stock prices were down by a marginal 0.67% as of the market closing on May 25th, 2021, bringing the price per share down to USD$1.48 at the end of the trading day. Subsequent pre-market fluctuations saw the stock skyrocket by 45.27%, bringing it up to USD$2.15. Positive Topline Results The company […]
